Related Experiment Videos

Infant cardiopulmonary bypass: a procoagulant state

J J Jaggers1, M C Neal, P K Smith

  • 1Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA. jagge003@mc.duke.edu

Insights

Infants undergoing cardiopulmonary bypass (CPB) show altered coagulation and fibrinolytic systems. Post-CPB serum induces endothelial procoagulant activity, indicating a potential hypercoagulable state in infants after cardiac surgery.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Cardiopulmonary bypass (CPB) in infants may lead to thrombotic and bleeding complications.
  • Tissue factor and prothrombinase activity on endothelial cells are key in activating the extrinsic clotting cascade.

Purpose of the Study:

  • To characterize the fibrinolytic and endothelial procoagulant state in infants undergoing congenital cardiac repairs.
  • To compare these states in infants with and without CPB.

Main Methods:

  • 14 infants (1-12 weeks) underwent cardiac repair (2 closed, 12 open).
  • Serum samples collected pre- and post-CPB (1, 4, 24 hours).
  • Measured tissue plasminogen activator, plasminogen activator inhibitor-1, IL-1beta, IL-6, tissue factor, and factor V. Assayed endothelial cell cultures for tissue factor and prothrombinase activity.

Main Results:

  • CPB-treated infants showed transient increases in tissue plasminogen activator and plasminogen activator inhibitor-1.
  • Endothelial tissue factor activity was induced post-CPB, with prothrombinase activity remaining elevated.
  • Serum factor V levels decreased significantly after CPB but recovered by 24 hours.

Conclusions:

  • Cardiopulmonary bypass disrupts coagulation and fibrinolytic systems in infants.
  • Post-CPB serum promotes endothelial procoagulant activity.
  • A hypercoagulable state may exist in infants during the post-CPB period.
Abstract

Related Concept Videos